Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, July 2000, p. 528-535, Vol. 7, No. 4
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Species-Specific Monoclonal Antibodies to
Escherichia coli-Expressed p36 Cytosolic Protein of
Mycoplasma hyopneumoniae
J.
Caron,
N.
Sawyer,
B. Ben Abdel
Moumen,
K.
Cheikh Saad
Bouh, and
S.
Dea*
Centre de Microbiologie et Biotechnologie,
INRS-Institut Armand-Frappier, Université du Québec,
Laval, Québec H7V 1B7, Canada
Received 30 September 1999/Returned for modification 24 January
2000/Accepted 10 March 2000
 |
ABSTRACT |
The p36 protein of Mycoplasma hyopneumoniae is a
cytosolic protein carrying species-specific antigenic determinants.
Based on the genomic sequence of the reference strain ATCC 25934, primers were designed for PCR amplification of the p36-encoding gene
(948 bp). These primers were shown to be specific to M. hyopneumoniae since no DNA amplicons could be obtained with other
mycoplasma species and pathogenic bacteria that commonly colonize the
porcine respiratory tract. The amplified p36 gene was subcloned into
the pGEX-4T-1 vector to be expressed in Escherichia coli as
a fusion protein with glutathione S-transferase (GST). The
GST-p36 recombinant fusion protein was purified by affinity
chromatography and cut by thrombin, and the enriched p36 protein was
used to immunize female BALB/c mice for the production of anti-p36
monoclonal antibodies (MAbs). The polypeptide specificity of the nine
MAbs obtained was confirmed by Western immunoblotting with cell lysates
prepared from the homologous strain. Cross-reactivity studies of the
anti-p36 MAbs towards two other M. hyopneumoniae reference
strains (ATCC 25095 and J strains) and Quebec field strains that had
been isolated in culture suggested that these anti-p36 MAbs were
directed against a highly conserved epitope, or closely located
epitopes, of the p36 protein. No reactivity was demonstrated against
other mycoplasma species tested. Clinical signs and lesions suggestive
of enzootic pneumonia were reproduced in specific-pathogen-free pigs
infected experimentally with a virulent Quebec field strain
(IAF-DM9827) of M. hyopneumoniae. The bacteria could be
recovered from lung homogenates of pigs that were killed after the
3-week observation period by both PCR and cultivation procedures.
Furthermore, the anti-p36 MAbs permitted effective detection by
indirect immunofluorescence of M. hyopneumoniae in frozen
lung sections from experimentally infected pigs. However, attempts to
use the recombinant p36 protein as an antigen in an indirect
enzyme-linked immunosorbent assay for the detection of antibodies in
sera from convalescent pigs showed no correlation with clinical and
pathological findings.
 |
INTRODUCTION |
Mycoplasma hyopneumoniae
is the causative agent of enzootic pig pneumonia (15, 21), a
disease found on pig farms worldwide which is characterized by high
morbidity and low mortality rates (19, 25). Coughing is the
principal clinical sign, and retarded growth and poor food conversion
may result in considerable economic losses. Furthermore, this agent
predisposes the pigs to secondary pulmonary infections, hence,
increasing the mortality among the herds and the financial problems
associated with such losses (19, 25).
M. hyopneumoniae encodes several characterized
immunodominant proteins, among which are the p36 cytosolic protein
(28, 29), the p46, p65, and p74 membranous proteins (3,
17, 18, 22), and the p97 adhesin (31). The functions
of these proteins have not been yet elucidated, but specific reactants
may eventually be useful tools for the diagnosis of M. hyopneumoniae.
The cytosolic p36 protein has been cloned, expressed and characterized
as a lactate dehydrogenase (16, 29). It has been shown to
induce an early immune response in pigs that were experimentally and
naturally infected by M. hyopneumoniae (10).
Furthermore, p36 is apparently highly conserved among different
M. hyopneumoniae strains from various parts of the world
(28, 29). Hyperimmune sera that have been produced against
the recombinant p36 protein showed no reactivity against other porcine
mycoplasmas, including M. flocculare, M. hyorhinis and Acholeplasma laidlawii (29). Furthermore, no cross-reactivity was demonstrated against
Mycoplasma or Acholeplasma species
isolated from humans, other farm animals, cats, and dogs
(29).
The diagnosis of M. hyopneumoniae is usually done by
cultivation of the organism or by immunofluorescence tests performed on
frozen thin lung sections using polyclonal antibodies (1, 7, 19,
20, 25). However, because of the fastidious nature of this
microorganism, its culture and identification may take up to 1 month.
The cultures are also often contaminated with M. hyorhinis,
which is an opportunistic agent that invades the lower respiratory
tract of pigs and overgrows M. hyopneumoniae in primary isolation attempts (9). Moreover, the overall efficacy of
serological detection methods, such as enzyme-linked immunosorbent
assays (ELISAs), is often hampered because of the potentially
cross-reacting antigenic relationships that exist between M. hyopneumoniae, M. flocculare, and M. hyorhinis (2, 9).
The indirect immunofluorescence (IIF) assay is still widely used for
the diagnosis of M. hyopneumoniae because it is a rapid and
convenient technique and allows histopathological observations. However, the use of polyclonal antisera may result in the nonspecific detection of other pathogens, namely, M. flocculare and
M. hyorhinis (2, 9, 24, 32). The use of
monoclonal antibodies (MAbs) increases the specificity of serological
and immunohistochemical tests (10, 26). This paper describes
the cloning and Escherichia coli-expression of the p36
protein of M. hyopneumoniae, the production and
characterization of anti-p36 MAbs, and their potential application in
IIF for the detection of the agent in frozen sections of lung tissues.
(This report was taken in part from a dissertation to be submitted by
J. Caron to the INRS-Institut Armand-Frappier, Université du
Québec, in partial fulfillment of the requirements for the M.Sc.
degree.)
 |
MATERIALS AND METHODS |
Microorganisms and growth conditions.
The ATCC 25934 strain
of M. hyopneumoniae was used as the reference strain in this
study. Other strains of M. hyopneumoniae (ATCC 25095 and J),
as well as M. flocculare (ATCC 27399), M. argininii (ATCC 23838), M. hyorhinis (ATCC 17981), and
A. laidlawii (ATCC 23206), were obtained from the American
Type Culture Collection, Manassas, Va., and used for comparative
antigenic studies. M. hyosynoviae was cultivated from a
field case of polyarthritis and was kindly provided to us by Claude
Montpetit, Ministère de l'Agriculture, des Pêcheries et de
l'Alimentation du Québec. The mycoplasmas were grown in modified
Friis medium (11), containing 20% porcine serum
(Gibco-BRL), 5% fresh yeast extract (Gibco-BRL), methicillin (0.15 mg/ml; Sigma-Aldrich Canada, Oakville, Ontario, Canada), bacitracin
(0.15 mg/ml; Sigma-Aldrich), and thallium acetate (0.08 mg/ml;
Sigma-Aldrich). The cells were harvested by centrifugation at
12,000 × g for 30 min at 4°C, washed three times,
and suspended in 0.1 M phosphate-buffered saline (PBS), pH 7.4.
Field isolates of M. hyopneumoniae were cultivated from lung
homogenates of pigs suffering from acute or chronic respiratory problems that had been forwarded to our laboratory for confirmation by
PCR of outbreaks of enzootic pneumonia in pig herds in Southern Quebec
(4).
DNA extraction and PCR conditions.
Genomic DNA from M. hyopneumoniae was extracted and purified, as previously described
(4). The oligonucleotide primers used for enzymatic
amplification of the entire open reading frame (ORF) of the p36 gene
(948 bp) of M. hyopneumoniae were selected from the
previously published DNA sequence (16) of the strain ATCC
25934 (GenBank accession no. X67286). The sequence of the forward
primer, FSp36, was 5' GGG CCG ATG AAA CCT ATT AAA ATA GCT 3', and that
of the reverse primer, RSp36, was 5' GCC GCG AAA TTA AAT ATT TTT AAT
TGC ATC CTG 3'. The sequence analysis for the primer selection was
performed using the McVector 3.5 (International Biothechnologies) and
Gene Works 2.2 (IntelliGeneticsInc., Mountain View, Calif.) programs.
The oligonucleotide primers were synthesized in an automated Gene
Assembler DNA synthesizer (Pharmacia LKB). The PCR protocol used for
amplification of the p36 gene was essentially similar to that described
previously (4). The PCR amplifications were performed in a
DNA Engine thermocycler (model PTC-100 with hot bonnet; MJ Research).
Aliquots (10 µl) of the amplified products were analyzed by
electrophoresis on 1% agarose gels (Boerhinger Mannheim) in TAE buffer
(0.04 M Tris-acetate [pH 8.5], 0.002 M EDTA) in the presence of
ethidium bromide at 100 V for 1 h and viewed under UV illumination.
Cloning, procaryotic expression, and purification of the GST-p36
recombinant fusion protein.
The complete ORF of the p36 gene (948 bp) was amplified by PCR as described above. The primers contained two
restriction sites for EcoRI (sense primer) and
BamHI (antisense primer) at their 5' ends for directional
cloning. The amplified products were purified by extraction with phenol
and chloroform and precipitation with 100% ethanol, digested with
EcoRI and BamHI, and ligated into the similarly
digested pGEX-4T-1 procaryotic vector, according to the manufacturer's
instructions (Pharmacia). The recombinant plasmid was used to transform
competent E. coli, strain BL21, cells (Gibco-BRL) to produce
the glutathione S-transferase (GST)-p36 fusion protein.
Briefly, overnight cultures of the transformed bacteria were diluted
1:100 in a total volume of 1.2 liters of 2YT medium containing
ampicillin (100 mg/ml) and 2% glucose, and grown at 37°C with
shaking (250 rpm) to an A600 of 0.8 to 1.0. Protein expression was induced by the addition of 0.1 mM
isopropyl-
-D-thiogalactopyranoside (IPTG), and after a 5 h-incubation at 37°C with vigorous agitation (250 rpm), the cells
were pelleted by centrifugation at 8,000 × g and
resuspended in 75 ml of ice-cold 0.1 M PBS [pH 7.4] containing lysozyme (1 mg/ml) and 1 mM phenylmethylsulfonyl fluoride (PMSF; Boehringer Mannheim). Cells were disrupted by sonication, and Triton
X-100 (Sigma-Aldrich) was added to a final concentration of 1%; this
was followed by an incubation of 30 min at room temperature to aid the
solubilization process. The soluble fusion protein was purified by
affinity chromatography on glutathione-Sepharose 4B beads (Pharmacia)
and either eluted with reduced glutathione (20 mM glutathione, 50 mM
Tris-HCl [pH 8.0], 120 mM NaCl) (27) or directly cleaved
through an overnight incubation with 18 U of thrombin to obtain the
enriched p36 moiety. The expressed recombinant protein was analyzed by
electrophoresis on sodium dodecyl sulfate (SDS)-12% polyacrylamide
gels after solubilization in 4× Laemmli disruption buffer and boiling
for 5 min.
Production of a monospecific anti-p36 rabbit hyperimmune
serum.
Two New-Zealand Albino rabbits were inoculated by the
intradermal route with 250 µg of the affinity-purified GST-p36
recombinant fusion protein emulsified in Freund's complete adjuvant
(Gibco-BRL). The rabbits received boosters twice at 2-week intervals by
the intramuscular route with the same amount of protein emulsified in
incomplete Freund adjuvant. Reactivity of the antisera to the native
p36 protein of M. hyopneumoniae was assessed by Western blotting for the complete antigen of the homologous strain.
Production and characterization of MAbs to the p36 gene of
M. hyopneumoniae.
Female BALB/c mice were immunized
intraperitoneally with 20 µg of affinity-purified p36 recombinant
protein mixed with Freund's complete or incomplete adjuvant for the
first and the three following injections, respectively. Injections were
given at 2-week intervals, followed by an intravenous dose of the
antigen without adjuvant 3 days prior to the fusion experiment. The
fusion protocol for sensitized splenocytes with P3 × 63 Ag8.653
myeloma cells was essentially similar to that described previously
(5). Hybrid cells were cultured in
hypoxantine-aminopterine-thymidine medium containing 10% fetal calf
serum. Hybridoma supernatants were screened for anti-p36 antibodies by
an indirect ELISA (14), the optimal p36 antigen
concentration, determined by checkerboard titration, corresponding to
0.15 µg of protein/well. In the ELISA, the washing buffer consisted
of 0.1 M PBS [pH 7.4] containing 0.05% Tween 80 (PBS-T), whereas the
saturation and dilution buffer consisted of PBS-T supplemented with 5%
goat serum and 4% skim milk (Blotto). The secreting hybridoma cells
were subcloned twice by serial dilutions. Immunoglobulin isotyping was
done using a commercial enzyme immunoassay (Boehringer Mannheim).
Ascitic fluids containing anti-p36 MAbs were obtained by
intraperitoneally injecting 1 × 106 to 2 × 106 cloned hybrid cells into 16-week-old female BALB/c mice
that had been primed 14 days before with 0.5 ml of pristane
(2,6,10,14-tetramethyl pentadecane; Sigma-Aldrich) (14).
Western immunoblotting.
Mycoplasma proteins separated by
SDS-12% polyacrylamide gel electrophoresis (PAGE) were
electrotransferred to nitrocellulose membranes (0.45-µm pore size;
Xymotech) for 2 h at 60 V, as previously described (5).
Membranes were blocked overnight in 0.02 M Tris-HCl buffer (pH 8.6)
containing 0.5% Tween 20 (TBS-T), 5% goat serum, and 5% skim milk.
Then, the membranes were incubated for 2 h at room temperature in
the presence of either a 1:1,000 dilution of rabbit hyperimmune serum,
a 1:200 to 1:1,000 dilution of porcine hyperimmune serum, or a 1:1,000
dilution of mouse ascitic fluid in the blocking buffer. The immune
reactions were revealed following incubation with a 1:2,000 dilution of
the appropriate peroxidase-labeled anti-immunoglobulin G (IgG)
conjugates and incubation in the enzyme substrate solution, as
described elsewhere (5).
Experimental infection of SPF pigs.
Six crossbred
F1 (Landrace × Yorkshire) castrated
specific-pathogen-free (SPF) piglets 9-to-10 weeks of age were obtained from a breeding farm located in Southern Quebec, Canada. The breeding stock and piglets were tested and proven to be seronegative for porcine
reproductive and respiratory syndrome virus, encephalomyocarditis virus, porcine parvovirus, hemagglutinating encephalomyelitis virus,
transmissible gastroenteritis virus, and M. hyopneumoniae. The piglets were randomly divided into two groups, each group being
allocated to separate isolation rooms in facilities equipped with a
microorganism-free filtered in-flowing and out-flowing air system. They
were fed commercial food and water ad libitum.
Two piglets kept as controls received 8 ml of fresh Friis medium given
intratracheally. The remaining four piglets received by the same route
8 ml of a culture of the IAF-DM9827 strain of M. hyopneumoniae corresponding to an infectious dose of
107 color-changing units/ml (highest dilution of the
culture that causes acidification of the medium within a 7-day
incubation period). The animals were monitored clinically for a 3-week
period, and then were euthanatized. Their lungs were aseptically
collected and processed for histopathology, PCR, and cultivation
attempts in modified Friis medium.
Histopathological examination.
Thin sections (5 µm thick)
of formalin-fixed, paraffin-embedded tissues from the lungs of control
and experimentally infected pigs were routinely processed for
hematoxylin-eosin staining.
Indirect immunofluorescence staining.
Thin frozen lung
sections showing typical enzootic pneumonia lesions were mounted on
glass slides and fixed with 100% ice-cold acetone. Once the slides
were dried, they were incubated with p36 MAbs at a dilution of 1:100,
washed in PBS, and reacted with fluorescein-conjugated goat anti-mouse
IgG (Boehringer Mannheim) diluted 1:40 in PBS. The fluorescent reaction
was observed under a UV microscope.
 |
RESULTS |
PCR amplification, cloning, expression, and purification of the
GST-p36 fusion protein.
As described in the previous section, the
PCR-amplified ORF (948 bp) of the p36 gene of M. hyopneumoniae (Fig. 1) and the procaryotic pGEX-4T-1 vector were both digested with EcoRI
and BamHI and successfully ligated. The recombinant plasmid
was used to transform competent E. coli cells, strain BL21,
which were then induced by the addition of IPTG in the culture medium
to express the fusion protein GST-p36. SDS-PAGE analysis of sonicates of IPTG-induced transformed E. coli cells revealed the
presence of an additional 60-kDa protein species, absent in noninduced bacteria, corresponding to GST (molecular mass of 24 kDa) fused to the
amino end of the cloned p36 protein (Fig.
2, lane 1). After bulk purification of
the induced sonicates on glutathione-Sepharose beads, 3.0 to 3.5 mg of
GST-p36 recombinant fusion protein was recovered from a culture of 1.2 liters of IPTG-induced and transformed bacteria (Fig. 2, lanes 4 and
5). To obtain purified recombinant p36 protein for immunization of mice
and rabbits, the GST-p36 recombinant fusion protein was digested
overnight with thrombin. The electrophoretic profile of the cleaved p36
portion of the fusion recombinant protein yielded a band migrating at
the expected size (Fig. 3, lanes 2 and
3). Cleavage of the GST-p36 recombinant fusion protein was complete,
with no residual uncut GST-p36 protein being detected by Western
blotting analysis (Fig. 3, lanes 1 to 3).

View larger version (73K):
[in this window]
[in a new window]
|
FIG. 1.
PCR amplification of the ORF encoding the cytosolic p36
protein of M. hyopneumoniae (strain ATCC 25934). Lane 1, a
948-bp DNA amplicon corresponding to the entire p36 gene was obtained
by PCR using the oligonucleotide primer pair FSp36 and RSp36; lane M,
the molecular sizes of three fragments of the 1-kb ladder.
|
|

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of the recombinant GST-p36 protein in
E. coli. Lane 1, IPTG-induced recombinant bacteria; lane 2, noninduced recombinant bacteria; lane 3, GST protein (24 kDa); lanes 4 and 5, purified GST-p36 recombinant fusion protein (60 kDa); lane M,
low-molecular-weight markers.
|
|

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 3.
Reactivity by Western immunoblotting of monospecific
rabbit hyperimmune serum to the recombinant GST-p36 fusion protein
prior to (lane 1) and after (lanes 2 and 3) cleavage by thrombin. Lane
M, low-molecular-weight markers.
|
|
Reactivity and specificity of the anti-p36 rabbit hyperimmune
serum.
As illustrated in Fig. 3, specific revelation of the
GST-p36 recombinant fusion protein (60 kDa) and its cut p36 moiety was obtained by Western blotting with the monospecific anti-p36 rabbit hyperimmune serum. This antiserum showed only a weak reactivity with
proteins of the nontransformed E. coli cells and failed
to react against complete antigenic preparations of M. hyorhinis, M. flocculare, M. arginini,
M. hyosynoviae, and A. laidlawii, thus
confirming the species specificity of the p36 cytosolic protein of
M. hyopneumoniae.
Production and characterization of anti-p36 MAbs.
BALB/c mice
that were injected with the purified p36 recombinant protein developed
a high specific antibody response, with antibody titers in serum
ranging from 12,800 to 51,200 as determined by indirect ELISA.
Following one fusion experiment, 11 hybridoma cell lines could be
established from which 9 were found to secrete anti-p36 antibodies.
These 9 hybridomas were subcloned by a limiting dilution method and
were subsequently expanded and retested before being injected
to pristane-primed mice to produce ascitic fluids. Using a commercial
isotyping kit (Boehringer Mannheim), all the MAbs were determined to be
of the IgG1 subclass and to possess kappa light chains. In all cases,
antibody titers above 51,200 were recovered from ascitic fluids. When
tested by Western blotting against the native and the cleaved
recombinant p36 protein, antibodies in ascitic fluids reacted very
strongly and specifically to both antigens (Fig.
4).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 4.
Reactivity of the anti-p36 MAbs against whole M. hyopneumoniae antigen (A) and against the cleaved recombinant p36
protein (B). Lanes 1, MAb 11C4; lanes 2, MAb 13B2; lanes 3, MAb 13B7;
lanes 4, MAb 13C9; lanes 5, MAb 13G3; lanes 6, MAb 15A3; lanes 7, MAb
15C2; lanes 8, MAb 15E10; lanes 9, 15H3; lanes 10, 15H3; lanes 11, prefusion mouse serum; lanes 12, normal mouse serum; lane M,
low-molecular-weight markers.
|
|
Species specificity of the anti-p36 MAbs.
The MAbs were tested
for their species specificity by Western blotting against complete
antigenic preparations of three reference strains of M. hyopneumoniae (ATCC 25934, ATCC 25095, and J) and those of other
porcine mycoplasma species, including A. laidlawii (Fig.
5). The antibodies reacted very
specifically to the three M. hyopneumoniae strains and
showed no reactivity with other mycoplasma species tested. Lack of
reactivity to other mycoplasma species was also confirmed by indirect
ELISA (data not shown).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 5.
Specificity of the anti-p36 MAbs as determined by
Western immunoblotting. The anti-p36 MAbs were tested for their
reactivity to three reference M. hyopneumoniae strains and
other mycoplasma species most commonly found in pigs. Lane 1, M. hyopneumoniae strain ATCC 25934; lane 2, M. hyopneumoniae strain J; lane 3, M. hyopneumoniae strain
ATCC 25095; lane 4, M. arginini; lane 5, M. flocculare; lane 6, M. hyorhinis; lane 7, A. laidlawii; lane 8, M. hyosynoviae; lane M,
low-molecular-weight markers.
|
|
Three Quebec field strains of M. hyopneumoniae, IAF-DM9827,
IAF-R202A, and IAF-20167, were cultivated in our laboratory, and the
reactivity of the anti-p36 MAbs to these strains was also verified
(Fig. 6B). The presence of the p36
protein in all of these three field strains was confirmed by Western
blotting with hyperimmune mouse and rabbit sera (Fig. 6A). In all
cases, a positive reaction was obtained with the nine anti-p36 MAbs,
suggesting the presence of at least one highly conserved antigenic
determinant (Fig. 6B, lanes 2 to 4).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 6.
Patterns of hyperimmune porcine serum (A) and anti-p36
MAbs (B) reactivity to the homologous and Quebec field strains of
M. hyopneumoniae. Lanes 1, homologous strain ATCC 25934;
lanes 2 to 4, Quebec field isolates IAF-DM9827, IAF-20167-20,
IAF-R202A. The sizes of the low-molecular-weight markers are indicated
to the left of each gel (lane M).
|
|
Clinical and pathological findings in experimentally infected
pigs.
The four SPF pigs that were infected intratracheally with a
culture of the IAF-DM9827 field strain of M. hyopneumoniae
did not manifest obvious clinical signs over the 3-week observation period. By the end of the first week postinfection (p.i.), the infected
pigs were apparently more apathic, reacted less to their environment,
and preferred to lay on the ground rather than stand. Compared to the
pigs in the control group, the infected pigs showed a little drop in
feed consumption, with a transitory mild fever (39.5 to 40.5°C) that
started by day 3 or 4 p.i. and persisted until the end of the
observation period. After 10 to 14 days p.i., coughing could be
elicited by exercising infected pigs around the pen, and it occurred
with greater frequency in the period immediately following the
exercise. Blood was collected from the control and infected pigs at 0, 7, 14, and 21 days p.i. to monitor the kinetics of p36 antibody
production by indirect ELISA. The majority of the pigs did not produce
significant antibody titers (<1:200) during the 3-week observation period.
Despite the low severity of the clinical signs, two infected pigs that
were euthanatized at day 21 p.i. had gross lesions that were
confined to the respiratory tract and thoracic cavity. The lung lesions
were confined almost entirely to the apical and cardiac lobes and were
clearly distinct from the normal lung tissue. Plum-colored or greyish
areas of consolidation resembling lymphoid tissue were scattered along
the ventral borders of the lobes. The mediastinal lymph nodes were
enlarged and congested. There was also slight accumulation of a
nonsuppurative exudate within the thoracic cavity (hydrothorax) and
pericardium (hydropericardium). The other organs were apparently
normal. To confirm an M. hyopneumoniae infection, PCR was
conducted on lung homogenates and attempts were made to isolate the
microorganism in culture. Expected DNA amplicons were obtained using
specific p36 PCR primers for M. hyopneumoniae, but no
reaction was observed using primer pairs designed to specifically
amplify the p37 gene of M. hyorhinis (4).
Following two serial passages in culture medium, growth of the
microorganism was obtained as noted by changes of the acidity and
turbidity of the medium. Confirmation that M. hyopneumoniae was the only microorganism growing in culture was obtained by PCR.
Microscopic lesions compatible with enzootic pneumonia were observed
within the lungs of infected pigs (Fig.
7). Characteristic perivascular and
peribronchiolar lymphomononuclear nodules of infiltration, often
compressing the lumen of the bronchioles, could be observed in both
euthanatized pigs. There were also pyknotic cell debris and few
mononuclear cells present in the lumen of the bronchioles, with
hyperplasia of the epithelial cells. The alveoli had a normal
appearance, with only a mild lymphomononuclear infiltration of the
interalveolar septae.

View larger version (122K):
[in this window]
[in a new window]
|
FIG. 7.
Histological findings in the lungs of control (A and B)
and experimentally infected (C and D) SPF pigs as shown by HPS
staining. (A) Spongiform aspect of the lung from a healthy pig, showing
clear airway passages (bronchioli and alveolar duct indicated by
arrows) and well-delineated interalveolar septae. (B) Normal appearance
of a bronchiolus. (C) General aspect of the lung of a pig that has been
infected with the IAF-DM9827 strain of M. hyopneumoniae,
with characteristic perivascular and peribronchiolar mononuclear cells
infiltration. No damage to the alveoli was observed, with only a mild
mononuclear infiltration of the alveolar septae. (D) Peribronchiolar
and perivascular accumulation of mononuclear cells with a mild
hyperplasia of the bronchiolar epithelium.
|
|
Detection of anti-p36 circulating antibodies and detection of
M. hyopneumoniae in lungs by indirect
immunofluorescence.
In preliminary attempts to evaluate the p36
indirect ELISA as a serological test for M. hyopneumoniae
infection, 45 field sera obtained from four farms in Southern Quebec
having experienced typical outbreaks of enzootic pneumonia were tested
in parallel using a commercial competitive ELISA (Dako Inc.), based on
the detection of antibodies to the p74 membranous protein
(8). Although percentages of competition with the anti-p74
MAbs varying from 35 to 90% were determined for most of the sera
tested, only a few demonstrated some reactivity when tested against the
p36 protein by indirect ELISA (data not shown). Therefore, no
correlation was obtained between A450 of test
serum/A450 negative serum ratios in the p36
indirect ELISA and percent competition values in the p74 ELISA.
On the other hand, when frozen sections of lungs from pigs that were
experimentally infected by M. hyopneumoniae (strain
IAF-DM9827) were processed for IIF staining using a pool of anti-p36
MAbs, positive fluorescence was generally associated with the presence of microscopic lesions. Fluorescent cells were usually observed lining
the bronchiolar epithelium and lining the wall of small alveolar
ducts (Fig. 8) but not within the lamina
propria or interstitial tissue surrounding those structures. No such
fluorescence was observed when lung sections were incubated with normal
mouse serum (data not shown).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 8.
Immunofluorescent staining with anti-p36 MAbs of frozen
sections of lungs from experimentally infected pigs. (A) Fluorescence
lining the bronchiolar epithelium; (B) fluorescence lining the wall of
alveolar ducts or small airways.
|
|
 |
DISCUSSION |
The use of mycoplasma recombinant proteins or gene probes
expressed in E. coli has been already reported either for
the study of the genes or as diagnostic tools (12, 13, 17, 18, 29, 30). Different MAbs have been produced against M. hyopneumoniae proteins, namely, against the p46 (22,
23) and p74 (8) membranous proteins, and the
respective MAbs have been used in double sandwich and competitive ELISA
tests for serological diagnosis of the infection. In the present study,
the pGEX-4T-1 expression vector was chosen for various reasons. First,
this procaryotic expression system has been shown to easily and rapidly
produce large quantities of pure proteins (24, 27) and
because of the presence of a thrombin protease recognition site
downstream of the GST coding sequence, which allows cleavage of the
desired protein from the fusion partner. Different incubation
temperatures and concentrations of IPTG used for the induction can be
tested to increase the level of production of the recombinant protein and to avoid its accumulation in the form of inclusion bodies (14,
24). Furthermore, the GST protein is not present in E. coli; hence, pig sera should not possess any antibodies that would react against this protein and interfere with data obtained from serological tests.
The p36 protein was chosen since it has been previously reported to be
highly specific and well conserved among the different strains of
M. hyopneumoniae (4, 28), it is antigenic
(12, 33), and there is no internal OPAL codon (TGA) in the
sequence of the encoding gene that interferes with efficient
translation of the entire protein (16). Recently, a single
PCR assay, using the primer pair FSp36-RSp36 to amplify the entire
encoding region of the p36 gene, was shown to be highly specific to
M. hyopneumoniae, with no reactivity being observed with
other mycoplasma species of swine (4). In the present study,
the entire p36-encoding region (948 bp) could be amplified from genomic
DNA of the reference ATCC strain 25934 of M. hyopneumoniae,
cloned and expressed in E. coli, yielding relatively large
amounts of GST-p36 recombinant fusion protein that could be easily
purified by affinity chromatography on glutathione-Sepharose 4B beads.
Efficient cleavage of the p36 moiety from the GST fusion partner was
achieved following digestion with thrombin. Both the fusion protein and
the cleaved p36 portion were stable at
80°C; barely any degradation
could be observed by SDS-PAGE.
The GST-p36 recombinant fusion protein was used to produce monospecific
polyclonal antiserum in rabbits. The latter was found to be specific to
M. hyopneumoniae by Western blotting reacting strongly
against the reference strains and all field strains cultivated in our
laboratory (data not shown). This monospecific hyperimmune serum failed
to recognize other mycoplasmas of the porcine species, as well as
A. laidlawii, thus confirming the species specificity of the
p36 cytosolic protein (4, 28). However, a mild
reactivity could be noticed against E. coli proteins, a
microorganism of the normal intestinal flora to which animals already
have significant circulating antibody titers (4, 28). The
production of anti-p36 MAbs was thus recognized to avoid such
reactivity towards antigenic proteins of heterologous bacteria which
may interfere or mask specific signals when using immunohistologic
methods for the detection of Mycoplasma antigens in tissues
of infected animals.
Nine secreting hybridoma cell lines producing MAbs to the p36
recombinant fusion protein were established and subcloned. From data
obtained in Western blotting experiments, the anti-p36 MAbs obtained
were apparently directed towards the same epitope or closely located
epitopes of the p36 cytosolic protein, which was found to be highly
preserved among all M. hyopneumoniae isolates tested, in
agreement with previous findings (27). Since all anti-p36
MAbs reacted by Western blotting against the native mycoplasma protein,
as well as the linear E. coli-expressed recombinant p36 protein, the anti-p36 MAbs obtained in the present study are probably directed against conformation-independent epitope(s).
IIF assay of frozen tissue sections is probably the most common
diagnostic tool used for the detection of M. hyopneumoniae in tissues of infected pigs (7, 19, 25). The IIF test has many advantages compared to cultivation methods; it is rapid and sensitive and allows one to quantify damages or lesions caused by
M. hyopneumoniae in the lungs or other tissues. However,
polyclonal antibodies are currently used in the IIF test (1, 7,
19, 20, 25). Consequently, false-positive results may arise
because of the cross-reactions existing between pathogenic (M. hyopneumoniae or M. hyosynoviae) and nonvirulent or
less virulent (M. flocculare or M. hyorhinis)
mycoplasma species (9). The use of MAbs which react to a
specific immunodominant protein of M. hyopneumoniae was
found to eliminate such undesirable cross-reactivities.
SPF pigs that were experimentally infected with a Quebec field isolate
(IAF-DM9827) of M. hyopneumoniae developed pulmonary lesions
compatible with a diagnosis of enzootic pneumonia, despite the absence
of severe respiratory signs (19, 25). Confirmation of an
M. hyopneumoniae infection was obtained by PCR performed on
lung homogenates and isolation of the pathogen in culture. Furthermore,
thin frozen sections of lung tissues were incubated in the presence of
a pool of anti-p36 MAbs, and a specific fluorescent reaction that was
limited to the epithelium lining bronchioles and small airways was
observed. As expected, no fluorescence was observed within the
interstitial tissues and lamina propria of the larger airways. In
agreement with the immunofluorescent patterns obtained in the present
study, M. hyopneumoniae has not been reported as a tissue
invader but is rather considered an extracellular pathogen which
associates very intimately with the ciliated epithelial cells of the
porcine lower respiratory tract (19, 25).
The IIF technique described in the present study is time-efficient,
taking 2 h to obtain the results once the sections are fixed. It
only requires a small volume of diluted antiserum for any given
reaction, and it is very specific. The p36 MAbs did not react with any
other mycoplasma species commonly found in the pig's respiratory tract
by Western blotting and ELISA. It is also a sensitive technique,
although the intensity of the fluorescence was directly proportional to
the quantity of lesions. Preliminary studies on tissues from naturally
infected pigs also yielded very interesting results, but the use of the
anti-p36 MAbs must be evaluated on a more representative number of
clinical cases before being used routinely for diagnostic purposes.
However, preliminary attempts to use the recombinant p36 protein as an
antigen in an indirect ELISA for the detection of antibodies in sera
from experimentally and naturally infected pigs showed no correlation
with clinical and pathological findings. The data obtained suggest that
the p36 protein, which is a cytosolic protein rather than a membranous
one, such as p46 and p74, is apparently weakly immunogenic and does not
trigger an efficient humoral response in pigs, which may explain the
unsuccessful results obtained when using the recombinant p36 protein as
antigen in an ELISA.
 |
ACKNOWLEDGMENTS |
We thank Louise Wilson and Diane Rouleau for their
excellent technical assistance. We also thank the following
pathologists and microbiologists from the Laboratoire de pathologie
animale, Ministère de l'Agriculture, des Pêcheries et de
l'Alimentation du Québec (MAPAQ), for their assistance in
obtaining clinical samples from sick pigs: Danielle Larochelle,
René Sauvageau, and Claude Montpetit. We acknowledge the
collaboration of José Daigneault, Pfizer Canda Inc.,
St-Hyacinthe, P.Q., for her clinical assistance.
This research was partly funded by the Conseil de Recherches en
Pêche et Agro-Alimentaire du Québec (grant 4600); BioVet Research Inc., St-Hyacinthe, Quebec, Canada; and the
Fédération des producteurs de porcs du Québec.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: INRS Institut
Armand-Frappier, Centre de Microbiologie et Biotechnologie, 531 Boulevard des Prairies, Laval, Québec, Canada, H7V 1B7. Phone:
(514) 687-5010, ext. 4219. Fax: (514) 686-5627. E-mail:
Serge_Dea{at}INRSIAF.UQUEBEC.CA.
 |
REFERENCES |
| 1.
|
Amanfu, W.,
C. N. Weng,
R. F. Ross, and H. J. Barnes.
1984.
Diagnosis of mycoplasmal pneumonia of swine: sequential study by direct immunofluorescence.
Am. J. Vet. Res.
45:1349-1352.
|
| 2.
|
Armstrong, C. H.,
M. J. Freeman, and L. Sands-Freeman.
1987.
Cross-reactions between Mycoplasma hyopneumoniae and Mycoplasma flocculare: practical implications for the serodiagnosis of mycoplasmal pneumonia of swine.
Isr. J. Med. Sci.
23:654-656[Medline].
|
| 3.
|
Brooks, E., and D. Faulds.
1989.
The Mycoplasma hyopneumoniae 74.5kD antigen elicits neutralizing antibodies and shares sequence similarity with heat-shock proteins.
Vaccine
89:265-269.
|
| 4.
|
Caron, J.,
M. Ouardani, and S. Dea.
2000.
Detection and differentiation of Mycoplasma hyopneumoniae and Mycoplasma hyorhinis by PCR amplification of the p36 and p46 genes.
J. Clin. Microbiol.
38:1390-1396[Abstract/Free Full Text].
|
| 5.
|
Dea, S., and P. Tijssen.
1989.
Antigenic and polypeptide structure of turkey enteric coronaviruses as defined by monoclonal antibodies.
J. Gen. Virol.
70:1725-1741[Abstract/Free Full Text].
|
| 6.
|
Dea, S.,
R. Bilodeau,
R. Sauvageau, and G. P. Martineau.
1991.
Outbreaks of respiratory and reproductive problems associated with encephalomyocarditis virus in Quebec pig farms.
J. Vet. Diagn. Investig.
3:275-282[Abstract/Free Full Text].
|
| 7.
|
Feenstra, A. A.,
V. Sörensen,
N. F. Friis,
N. E. Jensen, and V. Bille-Hansen.
1994.
Experimental Mycoplasma hyopneumoniae infection in pigs.
In
Proceedings of the 13th International Pig Veterinary Society CongressBangkok, Thailand.
|
| 8.
|
Feld, N. C.,
P. Qvist,
P. Ahrens,
N. F. Friis, and A. Meyling.
1992.
A monoclonal blocking ELISA detecting serum antibodies to Mycoplasma hyopneumoniae.
Vet. Microbiol.
30:35-46[CrossRef][Medline].
|
| 9.
|
Freeman, M. J.,
C. H. Armstrong,
L. L. Freeman-Sands, and M. Lopez-Osuna.
1984.
Serological cross-reactivity of porcine reference antisera to Mycoplasma hyopneumoniae, M. flocculare, M. hyorhinis and M. hyosynoviae indicated by the enzyme-linked immunosorbent assay, complement fixation and indirect hemagglutination tests.
Can. J. Comp. Med.
48:202-207[Medline].
|
| 10.
|
Frey, J.,
A. Haldimann,
M. Kobisch, and J. Nicolet.
1994.
Immune response against the L-lactate dehydrogenase of Mycoplasma hyopneumoniae in enzootic pneumonia of swine.
Microb. Pathog.
17:313-322[CrossRef][Medline].
|
| 11.
|
Friis, N. F.
1973.
The pathogenicity of Mycoplasma flocculare.
Acta Vet. Scand.
14:344-346[Medline].
|
| 12.
|
Frydenberg, J.,
K. Lind, and P. C. Hu.
1987.
Cloning of Mycoplasma pneumoniae DNA and expression of P1-epitopes in Escherichia coli.
Isr. J. Med. Sci.
23:759-762[Medline].
|
| 13.
|
Futo, S.,
Y. Seto,
M. Okada,
S. Sato,
T. Suzuki,
K. Kawai,
Y. Imada, and Y. Mori.
1995.
Recombinant 46-kilodalton surface antigen (P46) of Mycoplasma hyopneumoniae expressed in Escherichia coli can be used for early specific diagnosis of mycoplasmal pneumonia of swine by enzyme-linked immunosorbent assay.
J. Clin. Microbiol.
33:680-683[Abstract].
|
| 14.
|
Gonin, P.,
B. Pirzadeh,
C. A. Gagnon, and S. Dea.
1999.
Seroneutralization of porcine reproductive and respiratory syndrome virus correlates with antibody response to the GP5 major envelope glycoprotein.
J. Vet. Diagn. Investig.
11:20-26[Abstract/Free Full Text].
|
| 15.
|
Goodwin, R. F. W.,
A. P. Pomeroy, and P. Whittlestone.
1965.
Production of enzootic pneumonia in pigs with mycoplasma.
Vet. Rec.
77:1247-1249.
|
| 16.
|
Haldimann, A.,
J. Nicolet, and J. Frey.
1993.
DNA sequence determination and biochemical analysis of the immunogenic protein p36, the lactate dehydrogenase (LDH) of Mycoplasma hyopneumoniae.
J. Gen. Microbiol.
139:317-323[Medline].
|
| 17.
|
Kim, M. F.,
M. B. Heidari,
S. J. Stull,
M. A. McIntosh, and K. S. Wise.
1990.
Identification and mapping of an immunogenic region of Mycoplasma hyopneumoniae p65 surface lipoprotein expressed in Escherichia coli from a cloned genomic fragment.
Infect. Immun.
58:2637-2643[Abstract/Free Full Text].
|
| 18.
|
Klinkert, M. Q.,
R. Herrmann, and H. Schaller.
1985.
Surface proteins of Mycoplasma hyopneumoniae identified from an Escherichia coli expressed plasmid library.
Infect. Immun.
49:329-335[Abstract/Free Full Text].
|
| 19.
|
Kobish, M., and N. F. Friis.
1996.
Swine mycoplasmoses.
Rev. Sci. Off. Int. Epizootiol
15:1569-1606.
|
| 20.
|
Maes, D.,
M. Verdonck,
H. Deluyker, and A. de Kruif.
1996.
Enzootic pneumonia in pigs.
Vet. Q.
18:104-109[Medline].
|
| 21.
|
Maré, C. J., and W. P. Switzer.
1965.
Mycoplasma hyopneumoniae, a causative agent of virus pig pneumonia.
Vet. Med.
60:841-845.
|
| 22.
|
Mori, Y.,
T. Hamaoka, and S. Sato.
1987.
Use of monoclonal antibody in an enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against Mycoplasma hyopneumoniae.
Isr. J. Med. Sci.
23:657-662[Medline].
|
| 23.
|
Mori, Y.,
T. Hamaoka,
S. Sato, and S. Takeuchi.
1988.
Immunoblotting analysis of antibody response in swine experimentally inoculated with Mycoplasma hyopneumoniae.
Immunol. Immunopathol.
19:239-250.
|
| 24.
|
Nakano, H.,
T. Yamazaki,
M. Ikeda,
H. Masai,
S. Miyatake, and T. Saito.
1993.
Purification of glutathione S-transferase fusion proteins as a non-degraded form by using a protease-negative E. coli strain, AD202.
Nucleic Acids Res.
22:543-544[Free Full Text].
|
| 25.
|
Ross, R. F.
1992.
Mycoplasmal diseases, p. 537-551.
In
A. D. Leman, B. Straw, W. Mengeling, S. D'Allaire, and D. Taylor (ed.), Diseases of swine, 7th ed. Iowa State University Press, Ames.
|
| 26.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 27.
|
Smith, D. B., and K. S. Johnson.
1988.
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.
Gene
67:31-40[CrossRef][Medline].
|
| 28.
|
Stipkovits, L.,
J. Nicolet,
A. Haldimann, and J. Frey.
1991.
Use of antibodies against the p36 protein of Mycoplasma hyopneumoniae for the identification of M. hyopneumoniae strains.
Mol. Cell Probes
5:451-457[Medline].
|
| 29.
|
Strasser, M.,
J. Frey,
G. Bestetti,
M. Kobisch, and J. Nicolet.
1991.
Cloning and expression of a novel species-specific early immunogenic 36-kilodalton of Mycoplasma hyopneumoniae in Escherichia coli.
Infect. Immun.
59:1217-1222[Abstract/Free Full Text].
|
| 30.
|
Trevino, L. B.,
W. G. Haldenwang, and J. B. Baseman.
1986.
Expression of Mycoplasma pneumoniae antigens in Escherichia coli.
Infect. Immun.
53:129-134[Abstract/Free Full Text].
|
| 31.
|
Zhang, Q.,
T. Young, and R. F. Ross.
1995.
Identification and characterization of a Mycoplasma hyopneumoniae adhesin.
Infect. Immun.
63:1013-1019[Abstract].
|
Clinical and Diagnostic Laboratory Immunology, July 2000, p. 528-535, Vol. 7, No. 4
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cheikh Saad Bouh, K., Shareck, F., Dea, S.
(2003). Monoclonal Antibodies to Escherichia coli-Expressed P46 and P65 Membranous Proteins for Specific Immunodetection of Mycoplasma hyopneumoniae in Lungs of Infected Pigs. CVI
10: 459-468
[Abstract]
[Full Text]